=98% CAS-Nr (1388841-50-6)" /> =98%(1388841-50-6) information like chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight, physical properties,toxicity information,customs codes. You can also browse global suppliers,vendor,prices,Price,manufacturers of KPT 251, >=98%(1388841-50-6). At last,KPT 251, >=98%(1388841-50-6) safety, risk, hazard and MSDS, CAS,cas number,Use,cas no may also be you need." />

成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

KPT 251, >=98%

KPT 251, >=98% Struktur
1388841-50-6
CAS-Nr.
1388841-50-6
Englisch Name:
KPT 251, >=98%
Synonyma:
KPT251;AOB6639;KPT 251, >=98%;SCHEMBL11318201;SCHEMBL11318201; AOB6639;;2-[(Z)-2-{3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}vinyl]-1,3,4-oxadiazole;1,3,4-Oxadiazole, 2-[(1Z)-2-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]ethenyl]-;myeloid leukemia,Apoptosis,KPT 251,Chromosomal Maintenance 1,CRM1,inhibit,Exportin 1,KPT-251,melanoma,XPO1,A375,Inhibitor,antileukemic activity
CBNumber:
CB83066960
Summenformel:
C14H7F6N5O
Molgewicht:
375.23
MOL-Datei:
1388841-50-6.mol

KPT 251, >=98% Eigenschaften

Siedepunkt:
417.9±55.0 °C(Predicted)
Dichte
1.58±0.1 g/cm3(Predicted)
Aggregatzustand
Solid
pka
-0.42±0.50(Predicted)
Farbe
Off-white to yellow

Sicherheit

KPT 251, >=98% Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

KPT 251 is a novel CRM1 inhibitor, which has been shown to be effective in the treatment of acute myeloid leukemia.

KPT 251, >=98% Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

KPT 251, >=98% Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 35)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
TargetMol Chemicals Inc. 		+1-781-999-5354 +1-00000000000
 marketing@targetmol.com United States 32072 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD 		86-571-88216897,88216896 13588875226
 sales@hzclap.com CHINA 6312 58
Wuhan Topule Biopharmaceutical Co., Ltd 		+8618327326525
 masar@topule.com China 8467 58
Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd 		+86-18341751992 +86-15382112998
 757984502@qq.com China 892 58
Wuhan Jingkang en Biomedical Technology Co., Ltd 		+8613720134139
 orders@jknbiochem.com China 5221 58
Shanghai EFE Biological Technology Co., Ltd. 021-65675885 18964387627
 info@efebio.com China 9806 58
Shanghai Changyan Chem & Tech Co., Ltd. 021-20242659 18930833303
 Sales@changyanchem.cn China 5010 55
Lancrix Chemicals 86-21-50817262
sales@lancrix.com China 1502 55
Shanghai Rechem science Co., Ltd. 21-31433387 15618786686
 sales@rechemscience.com China 2984 58
Shanghai Han-Xiang Chemical Co., Ltd. 15971444841
 amber@biochempartner.com China 3061 58
  • KPT 251, >=98%
  • 2-[(Z)-2-{3-[3,5-Bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl}vinyl]-1,3,4-oxadiazole
  • KPT251
  • AOB6639
  • SCHEMBL11318201
  • SCHEMBL11318201; AOB6639;
  • myeloid leukemia,Apoptosis,KPT 251,Chromosomal Maintenance 1,CRM1,inhibit,Exportin 1,KPT-251,melanoma,XPO1,A375,Inhibitor,antileukemic activity
  • 1,3,4-Oxadiazole, 2-[(1Z)-2-[3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1-yl]ethenyl]-
  • 1388841-50-6
  • C14H7F6N5O
Copyright 2019 ? ChemicalBook. All rights reserved